Published in PLoS One on April 01, 2014
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet (1999) 37.76
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol (2001) 3.58
Systematic review of treatments for atopic eczema. Health Technol Assess (2000) 2.65
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol (2002) 2.41
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75
The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol (1994) 1.42
What is the cost of atopic dermatitis in preschool children? Br J Dermatol (2001) 1.40
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol (2002) 1.29
Management of atopic dermatitis in the pediatric population. Pediatrics (2008) 1.29
Atopic eczema: its impact on the family and financial cost. Arch Dis Child (1997) 1.29
Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS One (2012) 1.24
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics (2002) 1.22
Pimecrolimus: a review. J Eur Acad Dermatol Venereol (2003) 1.21
A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months. Br J Dermatol (2003) 1.20
New treatments for atopic dermatitis. BMJ (2002) 1.11
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr (2003) 1.08
Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology (2002) 1.06
Prevalence of childhood atopic dermatitis: an urban and rural community-based study in Shanghai, China. PLoS One (2012) 0.94
Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology (2004) 0.93
The epidemiology of atopic dermatitis. Monogr Allergy (1993) 0.92
A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. J Am Acad Dermatol (2004) 0.92
Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis. J Dermatolog Treat (2004) 0.91
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study. J Am Acad Dermatol (2005) 0.88
Pimecrolimus -- an anti-inflammatory drug targeting the skin. Exp Dermatol (2004) 0.87
Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis. J Dermatolog Treat (2006) 0.86
Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials. J Dermatolog Treat (2010) 0.85
Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parents' quality of life: a multicenter, randomized trial. Pediatr Allergy Immunol (2005) 0.84
Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. Br J Dermatol (2008) 0.83
Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity. Semin Cutan Med Surg (2001) 0.82
Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis. Dermatology (2004) 0.81
Topical pimecrolimus for eczema. Cochrane Database Syst Rev (2007) 0.81
Pimecrolimus: a review of pre-clinical and clinical data. Int J Clin Pract (2003) 0.80
Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome. Int J Dermatol (2005) 0.80
Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants. J Allergy Clin Immunol (2004) 0.80
Pimecrolimus: a review of its use in atopic dermatitis. Am J Clin Dermatol (2004) 0.78
Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis. Clin Ther (2006) 0.77
Trichoscopic findings of androgenetic alopecia and their association with disease severity. J Dermatol (2015) 0.75